| 000 | 01744 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516222218.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1651-2057 | ||
| 024 | 7 |
_a10.2340/00015555-1929 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVahlquist, Anders | |
| 245 | 0 | 0 |
_aRecurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab. _h[electronic resource] |
| 260 |
_bActa dermato-venereologica _cMar 2015 |
||
| 300 |
_a349-51 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcne Vulgaris _xdiagnosis |
| 650 | 0 | 4 |
_aAdalimumab _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCD18 Antigens _xgenetics |
| 650 | 0 | 4 |
_aCysts _xdiagnosis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukocyte-Adhesion Deficiency Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPyoderma Gangrenosum _xdiagnosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHåkansson, Lena Douhan | |
| 700 | 1 | _aRönnblom, Lars | |
| 700 | 1 | _aKarawajczyk, Malgorzata | |
| 700 | 1 | _aFasth, Anders | |
| 700 | 1 | _avan Gijn, Marielle E | |
| 700 | 1 | _aRoos, Dirk | |
| 700 | 1 | _aVenge, Per | |
| 773 | 0 |
_tActa dermato-venereologica _gvol. 95 _gno. 3 _gp. 349-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2340/00015555-1929 _zAvailable from publisher's website |
| 999 |
_c23981905 _d23981905 |
||